OMNIAB, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
OMNIAB, INC. (OABI) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $84.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-06
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $84.00K.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $39.00K, a 88.11% decline from fiscal 2023.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $328.00K, a 96.76% decline from fiscal 2022.
- OMNIAB, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $10.14M, a 30.17% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $84.00K 10-Q · filed 2026-08-06 | $84.00K derived: sum of 3 quarters · filed 2026-08-06 | $84.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $84.00K 10-Q · filed 2026-05-07 | $84.00K derived: sum of 2 quarters · filed 2026-05-07 | $84.00K derived: sum of 3 quarters · filed 2026-05-07 | $84.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $39.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $39.00K derived: sum of 3 quarters · filed 2026-03-04 | $39.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $39.00K derived: sum of 2 quarters · filed 2025-11-04 | $39.00K 10-Q · filed 2025-11-04 | $39.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $39.00K 10-Q · filed 2025-08-06 | $39.00K derived: sum of 3 quarters · filed 2025-08-06 | $39.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $328.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $328.00K derived: sum of 3 quarters · filed 2025-03-18 | $328.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $328.00K derived: sum of 2 quarters · filed 2024-11-12 | $328.00K 10-Q · filed 2024-11-12 | $592.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $328.00K 10-Q · filed 2024-08-08 | $592.00K derived: sum of 3 quarters · filed 2024-08-08 | $592.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $264.00K derived: sum of 2 quarters · filed 2024-05-09 | $264.00K derived: sum of 3 quarters · filed 2024-05-09 | $10.14M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $264.00K derived: sum of 2 quarters · filed 2024-03-25 | $10.14M derived: sum of 3 quarters · filed 2024-03-25 | $10.14M 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $9.87M derived: sum of 2 quarters · filed 2023-11-09 | $9.87M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $9.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $9.87M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $14.52M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |